These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12673715)

  • 1. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis.
    Zeegers MP; Jellema A; Ostrer H
    Cancer; 2003 Apr; 97(8):1894-903. PubMed ID: 12673715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age specific risks of familial prostate carcinoma: a basis for screening recommendations in high risk populations.
    Grönberg H; Wiklund F; Damber JE
    Cancer; 1999 Aug; 86(3):477-83. PubMed ID: 10430256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age at diagnosis and age at death in familial prostate cancer.
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Oncologist; 2009 Dec; 14(12):1209-17. PubMed ID: 19939895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary aspects of prostate cancer.
    McLellan DL; Norman RW
    CMAJ; 1995 Oct; 153(7):895-900. PubMed ID: 7553490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age specific and attributable risks of familial prostate carcinoma from the family-cancer database.
    Hemminki K; Czene K
    Cancer; 2002 Sep; 95(6):1346-53. PubMed ID: 12216104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?
    Zeegers MP; Kiemeney LA; Nieder AM; Ostrer H
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1765-71. PubMed ID: 15533905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher frequency of familial clustering of prostate cancer in French-Canadian men.
    Filion E; Taussky D; Bahary JP; Maugard CM
    J Urol; 2007 Oct; 178(4 Pt 1):1265-9; discussion 1270. PubMed ID: 17698103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
    Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
    Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case-cohort study on prostate cancer risk in relation to family history of prostate cancer.
    Schuurman AG; Zeegers MP; Goldbohm RA; van den Brandt PA
    Epidemiology; 1999 Mar; 10(2):192-5. PubMed ID: 10069259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk perception and concern among brothers of men with prostate carcinoma.
    Beebe-Dimmer JL; Wood DP; Gruber SB; Chilson DM; Zuhlke KA; Claeys GB; Cooney KA
    Cancer; 2004 Apr; 100(7):1537-44. PubMed ID: 15042690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial risk factors for prostate cancer.
    Carter BS; Steinberg GD; Beaty TH; Childs B; Walsh PC
    Cancer Surv; 1991; 11():5-13. PubMed ID: 1841757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreasing age at prostate cancer diagnosis over successive generations in prostate cancer families.
    Bock CH; Peyser PA; Montie JE; Cooney KA
    Prostate; 2005 Jun; 64(1):60-6. PubMed ID: 15651090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL.
    Canby-Hagino E; Hernandez J; Brand TC; Troyer DA; Higgins B; Ankerst DP; Thompson IM; Leach RJ; Parekh DJ
    Urology; 2007 Oct; 70(4):748-52. PubMed ID: 17991549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.
    Shaik AP; Jamil K; Das P
    Urol J; 2009; 6(2):78-86. PubMed ID: 19472123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of family history on outcomes in patients treated with definitive brachytherapy for clinically localized prostate cancer.
    Peters CA; Stock RG; Blacksburg SR; Stone NN
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):24-9. PubMed ID: 18692325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
    Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cohort study of cancer risk in relation to family histories of cancer in the Utah population database.
    Kerber RA; O'Brien E
    Cancer; 2005 May; 103(9):1906-15. PubMed ID: 15779016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer in first-degree relatives and risk of glioma in adults.
    Hill DA; Inskip PD; Shapiro WR; Selker RG; Fine HA; Black PM; Linet MS
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1443-8. PubMed ID: 14693735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
    Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
    Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate carcinoma among men with human immunodeficiency virus infection.
    Crum NF; Spencer CR; Amling CL
    Cancer; 2004 Jul; 101(2):294-9. PubMed ID: 15241826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.